HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Enteroviral meningoencephalitis in a patient with non-Hodgkin's lymphoma treated previously with rituximab.

Abstract
A 75-year-old man, with a long history of recurrent lymphoplasmacytoid lymphoma, presented with diffuse large-cell lymphoma affecting adrenal glands and causing severe hypoadrenalism. The lymphoma responded to rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone (R-CHOP) chemotherapy. Seven months postcompletion of chemotherapy, he developed signs of gastroenteritis and septicaemia. He deteriorated 24 h postadmission with a significant fall in Glasgow Coma Scale Score. Polymerase chain reaction testing of cerebrospinal fluid suggested enteroviral encephalitis. He responded symptomatically to intravenous immunoglobulins. His immunoglobulin levels were monitored weekly and supplemented to maintain immunoglobulin G level at 10 g/l, but in spite of this, his neurological condition deteriorated and he died after 14 weeks. Rituximab can cause prolonged B-cell deficiency. We speculate that profound immunosuppression induced by rituximab, together with previous chemotherapy, predisposed this patient to fatal enteroviral meningoencephalitis.
AuthorsB P Padate, J Keidan
JournalClinical and laboratory haematology (Clin Lab Haematol) Vol. 28 Issue 1 Pg. 69-71 (Feb 2006) ISSN: 0141-9854 [Print] England
PMID16430465 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Murine-Derived
  • Immunoglobulins, Intravenous
  • RNA, Viral
  • Rituximab
  • Vincristine
  • Doxorubicin
  • Cyclophosphamide
  • Prednisone
Topics
  • Aged
  • Antibodies, Monoclonal (administration & dosage, adverse effects)
  • Antibodies, Monoclonal, Murine-Derived
  • Antineoplastic Combined Chemotherapy Protocols (administration & dosage, adverse effects)
  • Cyclophosphamide (administration & dosage, adverse effects)
  • Doxorubicin (administration & dosage, adverse effects)
  • Enterovirus Infections (cerebrospinal fluid, drug therapy, etiology)
  • Fatal Outcome
  • Humans
  • Immunoglobulins, Intravenous (administration & dosage)
  • Immunosuppression Therapy (adverse effects)
  • Leukemia, Lymphocytic, Chronic, B-Cell (cerebrospinal fluid, complications, drug therapy, virology)
  • Meningoencephalitis (cerebrospinal fluid, drug therapy, etiology)
  • Prednisone (administration & dosage, adverse effects)
  • RNA, Viral (cerebrospinal fluid)
  • Rituximab
  • Vincristine (administration & dosage, adverse effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: